Resistance Development of Cystic Fibrosis Respiratory Pathogens When Exposed to Fosfomycin and Tobramycin Alone and in Combination under Aerobic and Anaerobic Conditions

Fosfomycin Enhances the Active Transport of Tobramycin in Pseudomonas aeruginosa

(2012) David L. MacLeod et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multidrug Therapy and Evolution of Antibiotic Resistance: When Order Matters

(2012) Gabriel G. Perron et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Sub-lethal concentrations of antibiotics increase mutation frequency in the cystic fibrosis pathogenPseudomonas aeruginosa

(2012) C.G. Nair et al.   LETTERS IN APPLIED MICROBIOLOGY

The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations

(2012) Anthony A. Fodor et al.   PLoS One

Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis withPseudomonasAirway Infection

(2011) Bruce C. Trapnell et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens

(2011) D. E. Karageorgopoulos et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions

(2011) Gerard McCaughey et al.   Journal of Cystic Fibrosis

Outpatient Treatment ofPseudomonas aeruginosaBronchial Colonization with Long-term Inhaled Colistin, Tobramycin, or Both in Adults without Cystic Fibrosis

(2011) David Berlana et al.   PHARMACOTHERAPY

Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis

(2011) M. M. Tunney et al.   THORAX

Frequency of Spontaneous Resistance to Fosfomycin Combined with Different Antibiotics in Pseudomonas aeruginosa

(2010) A. Rodriguez-Rojas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The continuing crisis in antibiotic resistance

(2010) G.L. French   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy

(2010) Antonio Oliver   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections

(2010) Alexandro Rodríguez-Rojas et al.   PLoS One

Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment

(2010) Giuseppe Valenza et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients

(2009) Paula King et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis

(2009) D. L. MacLeod et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis

(2008) Michael M. Tunney et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE